|
Hearken to this text  |
Velys Backbone, a system for planning and instrumenting spinal fusion procedures. | Credit score: J&J/DePuy Synthes
Johnson & Johnson’s DePuy Synthes this week launched a dual-use robotics and standalone navigation platform that makes use of its Velys robotic in backbone surgical procedure. This marks the most recent growth for Velys, J&J’s robotic orthopedic surgical procedure system that gained its first FDA clearance for complete knee surgical procedure in 2021. In June, Velys gained FDA clearance for unicompartmental knee arthroplasty.
The medtech big’s orthopedics unit developed the backbone surgical procedure Velys system in collaboration with eCential Robotics. eCential introduced FDA 510(okay) clearance for this platform final month. The businesses designed the Velys energetic robotic-assisted system (Velys Backbone) for planning and instrumenting spinal fusion procedures. Areas embrace the cervical, thoracolumbar and sacroiliac backbone.
DePuy Synthes mentioned the businesses purpose for the know-how to assist surgeons deal with their most complicated challenges. The twin-use system affords standalone navigation and an energetic robotics platform for flexibility in method and planning. Energetic robotics allows surgical steering tailor-made to surgeon choice.
The corporate mentioned the distinctive options and capabilities of energetic robotics might “set up a brand new normal in backbone surgical care.”
Velys Backbone affords a customizable expertise with pathology-specific workflows, aided by choices just like the Velys adaptive monitoring know-how and Velys trajectory help. It joins the DePuy Synthes core backbone portfolio of merchandise, the corporate mentioned.
DePuy Synthes — the most important orthopedic machine firm on this planet — anticipates full industrial availability within the first half of 2025.
“We’re shaping the subsequent frontier of orthopaedic innovation with a relentless deal with digital developments and excellence within the subject of surgical robotics and navigation,” mentioned DePuy Synthes chair Aldo Denti. “Our dedication extends to enhancing affected person care by means of vital strides in backbone surgical procedure. This can be a main step in rising our Velyx Portfolio and in our dedication to supporting backbone surgeons and their sufferers with superior instruments.”
In the meantime, competitor Stryker — which has seen a substantial amount of success with its Mako robotic surgical procedure methods — expects a Mako Backbone launch within the second half of 2024, with Mako Shoulder out by the tip of 2024.
